Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Completed(1)

Detailed Status

Recruiting2
Completed1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed125%
not_yet_recruiting125%
recruiting250%

Recent Activity

2 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

Exercise for Ameliorating Chemotherapy Cardiotoxicity

NCT06595316
recruitingnot_applicable

Early Warning and Intervention Mechanism of Foot Health Risk in Children and Adolescents

NCT06581978
recruitingnot_applicable

Marfan Syndrome Moderate Exercise Trial II

NCT05809323
completednot_applicable

Marfan Syndrome Moderate Exercise Pilot

NCT04641325

Clinical Trials (4)

Showing 4 of 4 trials
NCT06595316Not Applicable

Exercise for Ameliorating Chemotherapy Cardiotoxicity

Not Yet Recruiting
NCT06581978Not Applicable

Early Warning and Intervention Mechanism of Foot Health Risk in Children and Adolescents

Recruiting
NCT05809323Not Applicable

Marfan Syndrome Moderate Exercise Trial II

Recruiting
NCT04641325Not Applicable

Marfan Syndrome Moderate Exercise Pilot

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4